Resultados de la búsqueda - Portal de Modelos de Datos Médicos (MDM-Portal)

Filtrar resultados de búsqueda
Seleccionar modelos de datos

Modelos de datos seleccionados

Debe iniciar sesión para seleccionar modelos de datos para descargar o realizar un análisis.

1099 Resultados de la búsqueda.

E. Detailed information on the last 12 months Questionnaire for aftercare ABC study - E. Detailed information on the last 12 months Questionnaire for aftercare

- 23/11/16 - 1 formulario, 10 itemgroups, 115 items, 1 idioma

Itemgroups: occupation earnings, Level of Care, recreational activities; Self-help group support; Religious Group, Aftercare hospitalization hematologic neoplasm, Aftercare physician hematologic neoplasm, Medical Examination hematologic neoplasms, Aftercare rehabilitation measures hematologic neoplasm, Medication, Aftercare Physical therapy hematologic neoplasm, Aftercare hematologic neoplasm

Study part: E. Detailed information on the last 12 months Questionnaire for aftercare ABC Study. Aftercare pattern in adult patients with blood cancer and blood cancer early stage: Impact on health related endpoints, quality of life and health resource use. University clinic essen, (Klinik für Hämatologie Uniklinik Essen, UKE), department hematology. Permission granted by Claudia Ose.

D. Personal information and information about circumstances Questionnaire for aftercare ABC study - D. Personal information and information about circumstances Questionnaire for aftercare

- 21/11/16 - 1 formulario, 7 itemgroups, 62 items, 1 idioma

Itemgroups: Personal Information, Family history Neoplastic disease, health insurance previous, health insurance, Occupations, social contacts previous, social contacts

Study part: D. Personal information and information about circumstances Questionnaire for aftercare ABC Study. Aftercare pattern in adult patients with blood cancer and blood cancer early stage: Impact on health related endpoints, quality of life and health resource use. University clinic essen, (Klinik für Hämatologie Uniklinik Essen, UKE), department hematology. Permission granted by Claudia Ose.

Staging PETAL Study NCT00554164 - Staging

- 18/11/16 - 1 formulario, 9 itemgroups, 60 items, 2 idiomas

Itemgroups: Patient demographics, Therapy, Staging, Lab results, Nodal involvement, Extranodal involvement, Overall result, IPI, Footer module

Positronen-Emissionstomographie-gesteuerte Therapie aggressiver Non-Hodgkin-Lymphome (PETAL-Studie) Universitätsklinikum Essen (UK Essen) EudraCT-Nummer: 2006-001641-33 NCT00554164

Medical prescription and protocol Sedation and Analgesia Pediatric Hematology and Oncology UK Muenster

- 16/11/16 - 1 formulario, 6 itemgroups, 41 items, 2 idiomas

Itemgroups: Patient demographics, Prescription, Prescription of additional medication, Patient observation, Sedation protocol, criteria of discharge

Freigabe zur Verarbeitung durch Frau Prof. Rössig, Quellenangabe: "Pädiatrische Hämatologie und Onkologie, UKM" Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Münster Released for adaption by Frau Prof. Rössig Source:Pediatric Hematology und Oncology, University hospital Münster

Consent on genetic diagnostics Pediatric Hematology and Oncology UK Muenster

- 16/11/16 - 1 formulario, 1 itemgroup, 15 items, 2 idiomas

Itemgroup: Informed Consent

Freigabe zur Verarbeitung durch Frau Prof. Rössig, Quellenangabe: "Pädiatrische Hämatologie und Onkologie, UKM" Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Münster Released for adaption by Frau Prof. Rössig Source:Pediatric Hematology und Oncology, University hospital Münster

Eligibility Non-Hodgkin's Lymphoma NCT00491127

- 5/11/16 - 1 formulario, 2 itemgroups, 11 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

Cisplatin With Gemcitabine With Dexamethasone in Patients With Aggressive Non-Hodgkin's Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00491127

Eligibility Non-Hodgkin's Lymphoma NCT00387023

- 5/11/16 - 1 formulario, 2 itemgroups, 23 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

Radioimmunotherapy With 90Y Zevalin for Orbital Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00387023

Eligibility Non-Hodgkin's Lymphoma NCT00384553

- 4/11/16 - 1 formulario, 2 itemgroups, 16 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

Risk Adapted Therapy Optimization for Patients With Relapsed or Refractory Aggressive Non-Hodgkin-Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00384553

Eligibility Non-Hodgkins Lymphoma NCT00193505

- 4/11/16 - 1 formulario, 2 itemgroups, 18 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

Ifosfamide/Carboplatin/Etoposide/Rituxan Followed by Zevalin in Relapsed/Refractory Intermediate Grade B-Cell Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00193505

Eligibility Non-Hodgkins Lymphoma NCT00193479

- 4/11/16 - 1 formulario, 2 itemgroups, 16 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

Combination Chemotherapy and Rituximab With Pegfilgrastim Followed by Rituximab, in Large B-Cell Non-Hodgkin's Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00193479

Eligibility Non-Hodgkin's Lymphoma NCT00184002

- 4/11/16 - 1 formulario, 2 itemgroups, 18 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

Doxorubicin (Doxil) Combined With Rituxan, Cyclophosphamide, Vincristine and Prednisone in Newly Diagnosed Aggressive Non-Hodgkin's Lymphomas; ODM derived from: https://clinicaltrials.gov/show/NCT00184002

Eligibility Non-Hodgkin's Lymphoma NCT00151281

- 4/11/16 - 1 formulario, 2 itemgroups, 18 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

Phase II Study of RT-PEPC in Relapsed Mantle Cell Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00151281

Utilice este formulario para comentarios, preguntas y sugerencias.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.